{"id":250199,"title":"Notice to Stakeholders - Policy Statement on the Naming of Biologic Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T22:40:16.938000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-notice-to-stakeholders-drugs-naming-of-biologics.html?wbdisable=false","snippet":"Notice to Stakeholders - Policy Statement on the Naming of Biologic Drugs - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the workplace Immigration and…","rawSnapshotUrl":"/api/snapshots/raw/250199","browseUrl":"https://replay.healtharchive.ca/job-1/20250418224016/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-notice-to-stakeholders-drugs-naming-of-biologics.html?wbdisable=false#ha_snapshot=250199","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}